Gaetano Corazzelli

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial

Andrés JM Ferreri, Michele Reni, Marco Foppoli et al. · The Lancet · 2009 · 656 citations · Full text

Hematological Malignancy, Neuro-oncology, Lymphoid Neoplasia +9

Temozolomide as salvage treatment in primary brain lymphomas

Michele Reni, Francesco Zaja, Warren Mason et al. · British Journal of Cancer · 2007 · 178 citations · Full text

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

Andrés J.M. Ferreri, Stefania Dell’Oro, Marco Foppoli et al. · Neurology · 2006 · 93 citations

RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma

Gaetano Corazzelli, Ferdinando Frigeri, Filippo Russo et al. · British Journal of Haematology · 2011 · 76 citations

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

Gaetano Corazzelli, Gaetana Capobianco, Manuela Arcamone et al. · Cancer Chemotherapy and Pharmacology · 2009 · 75 citations

B-cell Lymphoma, Lymphoid Neoplasia, Hematological Malignancy +8